-a company focused on the development of continuous glucose monitoring devices.
Diabetes mellitus is a global pandemic and is one of the greatest causes of morbidity and mortality in the 21st century. It is a chronic, life-threatening illness with no cure likely to be available in the foreseeable future. The disease is caused by the body’s inability to effectively produce or utilize insulin.
Experts estimated that in 2000 over 170 million people in the world are afflicted with this illness. Diabetes related health care currently costs around $150bn in the USA.
Patients with diabetes must monitor their blood glucose levels regularly. This is commonly achieved through the use of test-strip based glucose meters which require finger-pricking to obtain a small blood sample. The more glucose values the patient can obtain the better the necessary therapy can be adjusted, leading to better patient outcomes. A minimally invasive, continuous glucose monitor would be the optimal glucose meter.
ABOYA will develop a reliable, pain-free continuous glucose monitor. Please read on the Technology page how ABOYA will achive this outstanding goal.